U.S. market Closed. Opens in 1 day 5 hours 35 minutes

FATE | Fate Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue63.53M96.30M55.85M31.43M10.68M4.74M4.11M4.40M2.43MN/A971.00K2.67M1.17M
Cost of Revenue161.70M13.76M5.85M125.62M87.77M56.02M34.36M26.45M19.86M16.43M12.01M12.00MN/A
Gross Profit-98.16M82.54M50.00M-94.19M-77.09M-51.28M-30.25M-22.05M-17.43M-16.43M-11.04M-9.33M1.17M
Operating Expenses254.04M404.69M272.84M159.52M111.41M71.83M46.23M36.37M30.21M24.90M18.65M16.23M14.46M
Selling, General & Admin79.45M84.23M57.32M33.90M23.64M15.81M11.87M9.91M10.35M8.47M6.64M4.23M4.61M
Research & Development172.60M320.45M215.52M125.62M87.77M56.02M34.36M26.45M19.86M16.43M12.01M12.00M9.86M
Other Operating ExpensesN/A20.82MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-190.51M-308.39M-216.99M-128.09M-100.73M-67.09M-42.12M-31.96M-27.78M-24.90M-17.68M-13.56M-13.29M
Other Expenses / Income29.58M26.66M4.84M-45.30M2.58M494.00K-827.00K-1.50M-2.21M-979.00K-3.22M-682.00K-134.00K
Before Tax Income-160.93M-281.72M-212.15M-173.39M-98.15M-66.60M-42.95M-33.46M-29.99M-25.88M-20.89M-14.24M-13.43M
Income Tax ExpensesN/A-26.66M-5.85M-3.09M-441.00K2.19M297.00K-743.00K-677.00K53.00K796.00K487.00K127.00K
Net Income-160.93M-255.06M-206.30M-170.30M-97.71M-66.60M-42.95M-33.46M-29.99M-25.88M-20.89M-14.24M-13.43M
Interest ExpensesN/A5.84MN/AN/A1.75M1.70M1.27M1.64M2.22M549.00K796.00K487.00K127.00K
Basic Shares Outstanding98.41M96.83M94.75M82.39M68.19M56.20M41.98M31.75M25.48M20.45M5.90M8.87M8.87M
Diluted Shares Outstanding98.41M96.83M94.75M82.39M68.19M56.20M41.98M31.75M25.48M20.45M5.90M8.87M8.87M
EBITDA-172.23M-294.63M-211.14M-125.00M-94.20M-63.70M-40.71M-30.94M-27.09M-24.41M-19.53M-13.16M-12.63M
EBITDA Margin-271.09%-305.95%-378.08%-397.65%-882.06%-1,343.84%-991.55%-702.95%-1,114.15%0.00%-2,011.02%-492.96%-1,079.32%
EBIT-160.93M-275.88M-212.15M-173.39M-96.40M-62.71M-41.39M-32.57M-28.45M-25.28M-19.30M-13.27M-13.17M
EBIT Margin-253.30%-286.48%-379.89%-551.59%-902.59%-1,323.04%-1,007.96%-739.85%-1,170.26%0.00%-1,987.85%-496.82%-1,125.90%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙